Systemic lupus erythematosus

• A study describing the efficacy and safety of belimumab administered subcutaneously in adult participants with early systemic lupus erythema … Recruiting
  2023-509146-35-00 6 2025-01-30 "Systemic Lupus Erythematosus"
• A clinical trial to learn about the effects of YTB in people with difficult to treat active systemic lupus erythematosus (SLE), or active k … Recruiting
  2023-510150-17-00 4 2024-12-11 "Active, refractory systemic lupus erythematosus (SLE), and "
• A study to learn if dapirolizumab pegol works and is safe in people with moderately to severely active systemic lupus erythematosus (SLE) Recruiting
  2023-508191-11-00 5 2024-11-28 "Systemic lupus erythematosus (SLE)"
• Long-term safety and tolerability of cenerimod in adults with systemic lupus erythematosus (OPUS OLE) Recruiting
  2024-514354-67-00 5 2024-11-01
• MB-CART19.1 in refractory SLE Recruiting
  2023-507654-33-00 9 2024-08-12 "Refractory systemic lupus erythematosus (SLE)"
• A Single-Arm, Open-Label, Phase 1 Study to Determine the Safety, Tolerability and Preliminary Efficacy of Obecabtagene Autoleucel in Patient … Recruiting
  2023-508236-60-00 3 2024-06-13 "Severe, Refractory Systemic Lupus Erythematosus"
• Phase 3 extension study to evaluate long-term safety of two regimens of ianalumab in participants with systemic lupus erythematosus (SIRIUS- … Recruiting
  2023-505929-14-00 5 2024-05-21 "Systemic Lupus Erythematosus"
• CAR-T cells in systemic B cell mediated autoimmune disease - CASTLE Recruiting
  2024-516819-24-00 9 2023-05-16 "Systemic Sclerosis"
• A randomized trial to investigate the reset of humoral autoimmunity by combining belimumab with rituximab in severe systemic lupus erythemat … Recruiting
  2023-507867-20-00 10 2018-10-04 "Lupus Erythematosus, Systemic"
• A research study to evaluate the efficacy and safety of cenerimod in subjects suffering from systemic lupus erythematosus Recruitment ended
  2024-515871-37-00 5 2024-10-24 "Moderate to severe systemic lupus erythematosus"
• A research study to evaluate the effects of a new oral medicine called cenerimod in adults with systemic lupus erythematosus Recruitment ended
  2024-515870-28-00 5 2024-10-22 "Moderate to severe systemic lupus erythematosus"
• A phase Ib, open-label, ascending dose study with step-up doses to assess safety, tolerability, and pharmacokinetics of PIT565 in participan … Recruitment ended
  2023-510025-14-00 3 2024-10-08 "Systemic Lupus Erythematosus"
• Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic … Recruitment ended
  2023-503655-10-00 5 2023-11-20 "Systemic Lupus Erythematosus (SLE)."
• Phase 2 Placebo-controlled Study to Assess the Safety, Efficacy, and PK of ESK-001 in SLE Recruitment ended
  2022-502105-15-00 4 2023-10-20
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants with Systemic Lupus Er … Recruitment ended
  2022-502632-39-00 1 2023-10-11 "Systemic Lupus Erythematosus (SLE)"
• Phase 3 study to evaluate ianalumab on top of standard-of-care therapy in patients with systemic lupus erythematosus (SIRIUS-SLE 2) Recruitment ended
  2023-508499-12-00 5 2023-05-17 "Systemic Lupus Erythematosus"
• An open-label study to assess safety, efficacy and cellular kinetics of YTB323 in severe, refractory systemic lupus erythematosus (srSLE). Recruitment ended
  2023-510081-27-00 9 2023-02-28 "Systemic Lupus Erythematosus."
• Phase 3 study to evaluate two regimens of ianalumab on top of standardof- care therapy in patients with systemic lupus erythematosus (SIRIUS … Recruitment ended
  2023-508498-97-00 5 2023-02-03 "Systemic Lupus Erythematosus"
• A Study to Evaluate the Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adults With Active Systemic Lupus Erythematosus (EMERALD) Recruitment ended
  2023-505635-13-00 5 2022-06-10
• Efficacy and safety of Frexalimab (SAR441344) in the treatment of Systemic Lupus Erythematosus Recruitment ended
  2023-508654-26-00 4 2022-03-15
• A Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background N … Recruitment ended
  2023-505696-74-00 5 2022-02-10 "systemic lupus erythematosus"
• A Study to Evaluate the Efficacy and Safety of BIIB059 (Litifilimab) in Adult Participants With Active Systemic Lupus Erythematosus Receivin … Recruitment ended
  2023-505695-30-00 5 2021-11-30 "systemic lupus erythematosus"
• Efficacy and Safety of Afimetoran Compared with Placebo in Participants with Active Systemic Lupus Erythematosus Recruitment ended
  2023-504320-25-00 4 2021-11-25 "Active Systemic Lupus Erythematosus"
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Patients with Systemic Lupus Erythematosus (ALLEGORY) Recruitment ended
  2023-504774-38-00 5 2021-11-04 "Systemic Lupus Erythematosus (SLE)"

Showing 25–48 of 61 trials